Tag: pharmaceutical safety assessment market share

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Pharmaceutical Safety Assessment Market Poised To Hit $16.96 Billion By 2030 With A 8.5% CAGR

The pharmaceutical safety assessment market size has demonstrated strong growth in recent years. It is anticipated to expand from $11.32 billion in 2025 to $12.24 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.2%. The expansion observed in prior periods can be attributed to factors such as the development of pharmaceutical research and development pipelines, increased regulatory oversight regarding drug safety, a rise in preclinical and clinical testing volumes, more widespread adoption of in-vitro safety assessment methodologies, and the increasing utilization of CRO-led safety studies.

The pharmaceutical safety assessment market is projected to experience robust expansion over the coming years. This market is forecast to reach $16.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast timeframe is primarily driven by an increased dependence on computational safety evaluations, the broadening scope of personalized medicine development, a growing need for quicker regulatory clearances, the escalating incorporation of AI into drug safety processes, and more stringent post-market surveillance mandates. Key developments expected within this period encompass the greater deployment of AI-powered toxicity prediction tools, an uptick in the acceptance of in-silico safety evaluation models, the expanding integration of real-time pharmacovigilance solutions, the proliferation of automated preclinical testing platforms, and a heightened emphasis on safety analytics that adhere to regulatory standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=29147&type=smp&name=Pharmaceutical%20Safety%20Assessment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pharmaceutical Safety Assessment Market Industry Drivers: What’s Behind The Revenue Growth?

The future expansion of clinical trials is expected to propel the growth of the pharmaceutical safety assessment market. Clinical trials represent research investigations conducted in humans to evaluate the safety, effectiveness, and side effects of new medical treatments, drugs, or interventions. The rise in clinical trials is attributed to the increasing demand for novel and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. These trials support pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing essential data that regulatory authorities use to ensure that medications are both effective and safe for public use. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, a total of 554,798 studies were registered on ClinicalTrials.gov as of September 26, 2025. Therefore, the expansion of clinical trials is driving the growth of the pharmaceutical safety assessment market.

Pharmaceutical Safety Assessment Market Breakdown By Product Type And Application

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

#Pharmaceutical Safety Assessment Market Growth Trends: What’s Shaping The Future Outlook?

Major companies in the pharmaceutical safety assessment market are concentrating on creating AI-driven decision support tools to enhance the precision and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that uses artificial intelligence to process data and provide insights, thereby supporting quicker and more accurate decision-making. For instance, in April 2024, Charles River Laboratories, a US-based life sciences company, in partnership with Deciphex, an Ireland-based company that enhances diagnostic precision and speed through AI-driven quality assurance, launched the Patholytix Foresight platform. This AI-powered decision support tool is specifically designed to revolutionize toxicologic pathology within pharmaceutical safety assessment. The platform utilizes artificial intelligence to rapidly analyze intricate preclinical pathology data, helping to identify potential safety risks sooner and reducing the subjective element in results. It offers distinct features such as an AI algorithm for detecting tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that minimizes slide review time while simultaneously improving data accuracy and consistency.

Pharmaceutical Safety Assessment Market Company Landscape And Competitive Strategy

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

View The Full Pharmaceutical Safety Assessment Market Report:

https://thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pharmaceutical Safety Assessment Market Largest Region By Revenue And Market Share

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Pharmaceutical Safety Assessment Market Forecast: What Market Value Is Expected By 2030?

The pharmaceutical safety assessment market has experienced robust expansion in recent times. Projected to rise from $11.32 billion in 2025 to $12.24 billion in 2026, this growth corresponds to a compound annual growth rate (CAGR) of 8.2%. Historically, this upward trend has been driven by the broadening of pharmaceutical research and development pipelines, heightened regulatory demands regarding drug safety, an uptick in preclinical and clinical testing activities, greater implementation of in-vitro safety evaluation techniques, and an increased reliance on contract research organizations for safety studies.

The pharmaceutical safety assessment market is projected to experience substantial growth in the coming years. By 2030, its value is anticipated to reach $16.97 billion, reflecting a compound annual growth rate (CAGR) of 8.5%. This expansion in the forecast period is driven by factors such as a growing dependence on computational safety evaluation, the broadening of personalized medicine development, heightened demand for expedited regulatory approvals, greater incorporation of artificial intelligence into drug safety operations, and increased requirements for post-market surveillance. Key trends shaping this period include more widespread application of AI-driven toxicity prediction tools, a growing reliance on in-silico safety assessment methods, deeper integration of real-time pharmacovigilance systems, broader adoption of automated platforms for preclinical testing, and a stronger emphasis on safety analytics that meet regulatory standards.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmaceutical Safety Assessment Market Opportunity Drivers: What Is Creating New Revenue Potential?

The anticipated growth of the pharmaceutical safety assessment market is being driven forward by the expanding scope of clinical trials. These trials are defined as human research studies that assess the safety, efficacy, and potential side effects of novel medical treatments, drugs, or interventions. An upsurge in clinical trials is occurring because of an increased demand for innovative and effective therapies, as researchers and healthcare professionals strive to develop improved methods for preventing, managing, or curing diseases. Through systematically examining a drug’s impact on humans in tightly controlled settings, monitoring for adverse events, establishing safe dosage levels, and generating critical data for regulatory bodies to confirm that medications are both safe and effective for public consumption, clinical trials play a key role in supporting pharmaceutical safety assessment. For example, the National Library of Medicine (NLM), a US-based biomedical library, reported that by September 26, 2025, 554,798 studies were registered on ClinicalTrials.gov. Consequently, the increasing number of clinical trials is fueling growth in the pharmaceutical safety assessment market.

Pharmaceutical Safety Assessment Market Segment Landscape And Growth Potential

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

Pharmaceutical Safety Assessment Market Innovation Trends Driving Future Development

Major players in the pharmaceutical safety assessment sector are placing growing emphasis on the creation of AI-driven decision support systems aimed at boosting both the precision and effectiveness of toxicity prediction and safety profiling. Such a system constitutes software that leverages artificial intelligence to interpret data, thereby generating insights conducive to quicker and more reliable decision-making. A case in point occurred in April 2024, when Charles River Laboratories—a life sciences firm based in the United States—teamed up with Deciphex, an Irish company that enhances diagnostic speed and accuracy through AI-based quality control, to unveil the Patholytix Foresight platform. This AI-enabled decision support tool seeks to revolutionize toxicologic pathology within pharmaceutical safety evaluations. By rapidly processing intricate preclinical pathology data through artificial intelligence, the platform can flag potential safety issues earlier and minimize the subjectivity embedded in outcomes. Among its distinct attributes are an AI algorithm capable of detecting alterations in tissues, a cloud-hosted infrastructure enabling worldwide cooperation, and an expandable architecture that cuts down on the time needed for slide review while simultaneously elevating data precision and operational efficiency.

Pharmaceutical Safety Assessment Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Access The Complete Pharmaceutical Safety Assessment Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmaceutical Safety Assessment Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Pharmaceutical Safety Assessment Market During The 2026–2030 Period?

The pharmaceutical safety assessment market has seen significant growth in recent years. This market is anticipated to expand from $11.32 billion in 2025 to $12.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. The historical expansion of the market can be linked to the broadening of pharmaceutical R&D pipelines, increased regulatory oversight concerning drug safety, a rise in preclinical and clinical testing activities, greater adoption of in-vitro safety assessment methods, and the growing reliance on CRO-conducted safety studies.

The pharmaceutical safety assessment market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $16.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. The expansion during the forecast period is attributable to an increasing reliance on computational safety assessment, the broadening scope of personalized medicine development, a rising demand for faster regulatory approvals, the growing integration of AI in drug safety workflows, and increased post-market surveillance requirements. Key trends expected in the forecast period include the increasing use of AI-based toxicity prediction tools, the rising adoption of in-silico safety assessment models, the growing integration of real-time pharmacovigilance systems, the expansion of automated preclinical testing platforms, and an enhanced focus on regulatory-compliant safety analytics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

What Important Drivers Are Powering The Pharmaceutical Safety Assessment Market Growth?

The expansion of clinical trials is anticipated to drive the growth of the pharmaceutical safety assessment market moving forward. Clinical trials represent research investigations conducted in humans to assess the safety, effectiveness, and potential side effects of new medical treatments, drugs, or interventions. The rise in these trials is due to the increasing necessity for novel and effective treatments, as researchers and healthcare providers aim to develop therapies capable of better preventing, managing, or curing diseases. Clinical trials support pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, establishing safe dosage ranges, and supplying essential data that regulatory authorities utilize to ensure medications are both effective and safe for public use. For instance, in September 2025, the National Library of Medicine (NLM), a US-based biomedical library, reported a total of 554,798 studies registered on ClinicalTrials.gov as of September 26, 2025. Therefore, the broadening of clinical trials is a key factor propelling the growth of the pharmaceutical safety assessment market.

Which Segment Divisions Form The Structure Of The Pharmaceutical Safety Assessment Market?

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

What Trends Are Affecting The Growth Of The Pharmaceutical Safety Assessment Market?

Leading companies in the pharmaceutical safety assessment market are concentrating their efforts on developing AI-powered decision support tools, aimed at boosting the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is essentially a software system that uses artificial intelligence to analyze data, providing insights that facilitate faster and more precise decision-making. As an illustration, in April 2024, Charles River Laboratories, a US-based life sciences company, partnered with Deciphex, an Ireland-based company recognized for enhancing diagnostic precision and speed via AI-driven quality assurance, to launch the Patholytix Foresight platform. This AI-powered decision support tool is specifically designed to transform toxicologic pathology within pharmaceutical safety assessment. The platform leverages artificial intelligence to rapidly analyze complex preclinical pathology data, which helps in identifying potential safety risks sooner and reduces subjectivity in results. It features unique attributes such as an AI algorithm capable of detecting tissue abnormalities, a cloud-based system enabling global collaboration, and a scalable design that minimizes slide review time while concurrently improving data accuracy and consistency.

Which Firms Are Competing In The Pharmaceutical Safety Assessment Market?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Access The Complete Pharmaceutical Safety Assessment Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

Which Region Leads The Pharmaceutical Safety Assessment Market By Size?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmaceutical Safety Assessment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company

Pharmaceutical Chemicals Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Pharmaceutical Safety Assessment Market Between 2026 And 2030?

The pharmaceutical safety assessment market has experienced significant growth in recent years. This market is forecast to expand from $11.32 billion in 2025 to $12.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. The historical increase in market size can be attributed to the enlargement of pharmaceutical R&D pipelines, heightened regulatory scrutiny on drug safety, a rise in preclinical and clinical testing volumes, the broader implementation of in-vitro safety assessment methods, and the increasing utilization of CRO-led safety studies.

The pharmaceutical safety assessment market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $16.97 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.5%. The projected growth during this period stems from several factors, including a greater dependence on computational methods for safety assessment, the broadening scope of personalized medicine development, an escalating need for expedited regulatory approvals, the increasing incorporation of AI into drug safety processes, and more stringent post-market surveillance mandates. Key trends anticipated during the forecast timeframe encompass the increasing deployment of AI-based tools for toxicity prediction, a growing embrace of in-silico safety assessment models, the expanded integration of real-time pharmacovigilance systems, the proliferation of automated preclinical testing platforms, and a heightened emphasis on safety analytics that adhere to regulatory standards.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

Which Strong Drivers Are Impacting The Pharmaceutical Safety Assessment Market Growth?

The increased scale of clinical trials is anticipated to drive the future growth of the pharmaceutical safety assessment market. These trials represent research conducted on humans to evaluate the safety, efficacy, and side effects of new medical treatments, drugs, or interventions. The rise in clinical trials is due to the growing demand for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials bolster pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing essential data that regulatory authorities use to ensure that medications are both effective and safe for public use. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, as of September 26, 2025, a total of 554,798 studies were registered on ClinicalTrials.gov. Thus, the expansion of clinical trials is fueling the growth of the pharmaceutical safety assessment market.

Which Segment Classifications Are Used In The Pharmaceutical Safety Assessment Market Segment Analysis?

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

What Trends Are Transforming The Pharmaceutical Safety Assessment Market?

Leading companies in the pharmaceutical safety assessment market are concentrating on developing AI-driven decision support tools to enhance the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that uses artificial intelligence to analyze data and provide insights, thereby supporting faster and more accurate decision-making. For instance, in April 2024, Charles River Laboratories, a US-based life sciences company, in partnership with Deciphex, an Ireland-based company that enhances diagnostic precision and speed through AI-driven quality assurance, launched the Patholytix Foresight platform. This AI-powered decision support tool is designed to transform toxicologic pathology in pharmaceutical safety assessment. The platform utilizes artificial intelligence to swiftly analyze complex preclinical pathology data, helping identify potential safety risks earlier and reducing subjectivity in results. It offers unique features such as an AI algorithm that detects tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that cuts down slide review time while improving data accuracy and consistency.

Which Firms Are Contributing To The Pharmaceutical Safety Assessment Market Ecosystem?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Get The Full Pharmaceutical Safety Assessment Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

Which Geographic Region Dominates The Pharmaceutical Safety Assessment Market?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceutical Safety Assessment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company

Pharmaceutical Chemicals Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Pharmaceutical Safety Assessment Market Over The Period 2026–2030?

The pharmaceutical safety assessment market size has shown significant expansion in recent years. It is projected to increase from $11.32 billion in 2025 to $12.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to the broadening of pharmaceutical R&D pipelines, heightened regulatory scrutiny on drug safety, an increase in preclinical and clinical testing volumes, the expanded adoption of in-vitro safety assessment methods, and the rising utilization of CRO-led safety studies.

The pharmaceutical safety assessment market is poised for robust expansion over the coming years. Its valuation is projected to reach $16.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast period stems from factors such as a greater reliance on computational safety evaluation, the broadening scope of personalized medicine development, an escalating need for expedited regulatory clearances, the increasing incorporation of AI in drug safety processes, and elevated post-market surveillance mandates. Key trends defining this period encompass the expanded deployment of AI-powered toxicity prediction tools, an uptick in the embrace of in-silico safety evaluation models, the progressive integration of real-time pharmacovigilance frameworks, the proliferation of automated preclinical testing platforms, and a heightened emphasis on safety analytics that conform to regulatory standards.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

Which Economic Or Industry Drivers Are Impacting The Pharmaceutical Safety Assessment Market?

The expansion of clinical trials is projected to fuel the advancement of the pharmaceutical safety assessment market moving forward. Clinical trials are defined as human research studies conducted to evaluate the safety, effectiveness, and potential side effects of new medical treatments, drugs, or interventions. The rise in clinical trials is driven by the increasing need for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials bolster pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing vital data that regulatory authorities use to ensure medications are both effective and safe for public consumption. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, a total of 554,798 studies were registered on ClinicalTrials.gov as of September 26, 2025. Therefore, the growth of clinical trials is a significant driver for the pharmaceutical safety assessment market.

How Is The Pharmaceutical Safety Assessment Market Divided Into Its Major Segments?

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

How Are Trends Transforming The Pharmaceutical Safety Assessment Market Landscape?

Leading companies in the pharmaceutical safety assessment market are concentrating on creating AI-driven decision support tools to boost the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool functions as a software system that utilizes artificial intelligence to examine data and yield insights, thereby supporting faster and more precise decision-making. As an illustration, in April 2024, Charles River Laboratories, a US-based life sciences company, in collaboration with Deciphex, an Ireland-based company renowned for improving diagnostic precision and speed through AI-driven quality assurance, unveiled the Patholytix Foresight platform. This AI-powered decision support tool is specifically designed to transform toxicologic pathology within pharmaceutical safety assessment. The platform leverages artificial intelligence to rapidly analyze intricate preclinical pathology data, aiding in the earlier detection of potential safety risks and minimizing subjectivity in outcomes. Its distinct features comprise an AI algorithm capable of detecting tissue abnormalities, a cloud-based system for global collaboration, and a scalable architecture that reduces slide review duration while enhancing data accuracy and consistency.

Who Are The Prominent Organizations Shaping The Pharmaceutical Safety Assessment Market?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Read the full pharmaceutical safety assessment market report here:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

What Are The Top-Performing Regions Within The Pharmaceutical Safety Assessment Market?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmaceutical Safety Assessment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29147&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company

Pharmaceutical Chemicals Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical safety assessment market from 2026–2035 with trusted insights from The Business Research Company

How is the Pharmaceutical Safety Assessment Market size predicted to change over the forecast window of 2026–2035?

The pharmaceutical safety assessment market size has exhibited strong growth in recent years. It is forecast to rise from $11.32 billion in 2025 to $12.24 billion in 2026, at a compound annual growth rate (CAGR) of 8.2%. This historical growth can be attributed to several factors, including the expansion of pharmaceutical R&D pipelines, increased regulatory scrutiny on drug safety, a rise in preclinical and clinical testing volumes, broader adoption of in-vitro safety assessment methods, and the growing utilization of CRO-led safety studies.

The pharmaceutical safety assessment market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $16.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This expansion during the forecast period is primarily driven by factors such as a greater dependence on computational safety assessment, the broadening development of personalized medicine, an escalating need for quicker regulatory approvals, the increasing incorporation of AI into drug safety processes, and more stringent post-market surveillance mandates. Key trends anticipated over this period encompass a rise in the deployment of AI-based tools for toxicity prediction, an increased embrace of in-silico safety assessment models, the expanding integration of real-time pharmacovigilance systems, the broadening of automated preclinical testing platforms, and a heightened emphasis on safety analytics that comply with regulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

Which Drivers Are Contributing To The Expansion Of The Pharmaceutical Safety Assessment Market?

The expansion of clinical trials is projected to stimulate the growth of the pharmaceutical safety assessment market in the coming years. Clinical trials involve research studies conducted in human subjects to assess the safety, effectiveness, and potential side effects of new medical treatments, drugs, or interventions. The increase in clinical trials stems from the growing necessity for new and effective treatments, as researchers and healthcare professionals strive to develop therapies that can more effectively prevent, manage, or cure diseases. These trials contribute to pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, establishing safe dosage ranges, and providing essential data that regulatory authorities use to confirm that medications are both effective and safe for public consumption. For example, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, a total of 554,798 studies were registered on ClinicalTrials.gov as of September 26, 2025. Consequently, the expansion of clinical trials is a significant factor driving the growth of the pharmaceutical safety assessment market.

What Segment Classifications Make Up The Pharmaceutical Safety Assessment Market?

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

What Upcoming Trends Are Likely To Define The Future Path Of The Pharmaceutical Safety Assessment Market?

Key companies in the pharmaceutical safety assessment market are concentrating on developing AI-driven decision support tools to improve the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that utilizes artificial intelligence to analyze data and offer insights, supporting faster and more precise decision-making. For example, in April 2024, Charles River Laboratories, a US-based life sciences company, in collaboration with Deciphex, an Ireland-based company specializing in enhancing diagnostic precision and speed through AI-driven quality assurance, unveiled the Patholytix Foresight platform. This AI-powered decision support tool is specifically designed to transform toxicologic pathology in pharmaceutical safety assessment. The platform employs artificial intelligence to swiftly analyze intricate preclinical pathology data, assisting in the earlier identification of potential safety risks and decreasing subjectivity in results. It provides distinct features, including an AI algorithm for detecting tissue abnormalities, a cloud-based system facilitating global collaboration, and a scalable design that reduces slide review time while concurrently boosting data accuracy and consistency.

Which Leading Companies Dominate The Pharmaceutical Safety Assessment Market Share?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

How Does The Pharmaceutical Safety Assessment Market Perform Across Major Global Regions?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceutical Safety Assessment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=29147&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company

Pharmaceutical Chemicals Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model